Tashkenbayeva E.N (1), Mukhiddinov A.I (2)
Study of modern methods for diagnosing arterial hypertension in people with COVID-19. Materials and methods: in the study, 221 patients with COVID-19 were divided into three groups, the 1st - 94 patients with COVID-19 and arterial hypertension receiving standard treatment, and the 3rd group consisted of 35 healthy controls. The comparison group consisted of 92 patients with COVID-19 without arterial hypertension. Results: in patients in the control group with progressive COVID-19 on the background of arterial hypertension, the quality of life after treatment was assessed from 36.2±0.7 to 27.3±1.3 points in stage II of the disease, and from 46.2±1.7 to 30.2±1.6 points in stage III. Conclusion: patients with arterial hypertension are a risk group for the development of cardiovascular complications and require constant monitoring and specific therapeutic approaches.
1. Bazdyrev E.D. Corona virus infection is an actual problem of the 21st century // Kompleks. problem Serdechno-Sosud. psalm - 2020. -T. 9, No. 2. - S. 6-16.1
2. Barbarash O.L., Karetnikova V.N., Kashtalap V.V. i dr. The novel coronavirus disease (COVID-19) and cardiovascular disease // Kompleks. problem Serdechno-Sosud. psalm - 2020. - T. 9, No. 2. - S. 17-28.2
3. Belenkov Yu.N., Snejitsky V.A., Ardashev A.V. i dr. Recommendations of the Eurasian Arithmological Association (EURA) for the diagnosis and treatment of patients with arrhythmias and during the COVID-19 pandemic // Cardiology. - 2020. - T. 60, No. 5. - S. 4-8.3
4. Belyakov N.A., Rassokhin V.V., Yastrebova E.B. koronavirusnaya infection COVID-19. nature of the virus, pathogenesis, clinical manifestations. Soobshchenie 1 // HIV-infection and immunosuppression. - 2020. - T. 12, No. 1. - S. 7-21.4
5. Boytsov S.A., Balanova Yu.A., Shalnova S.A. i dr. Arterial hypertension among patients 25-64 years old: rasprostranennost, consciousness, treatment and control. Po materialam issledovaniya ESSE. // Cardiovasc. sweat prof. – 2014. – No. 4. - S. 4-14. DOI: 10.15829/1728-8800-2014-4-4-14 5
6. VOZ. Clinical management of patients with severe acute respiratory infections suspected of being infected with the new coronavirus (2019-nCoV). Time management on January 28, 2020. WHO/nCoV/Clinical/2020.6
7. Golukhova E.Z., Sokolova N.Yu., Bulaeva N.I. Vzglyad kardiologi na problemu pandemii novoy koronavirusnoy infektsii COVID-19 (obzor literatury) // Kreativnaya kardiol. - 2020. - T. 14, No. 1. - S. 5-15.8
8. Grinevich V.B., Gubonina I.V., Doshchitsin V.L. i dr. Peculiarities of the behavior of comorbid patients and the period of the new coronavirus infection (COVID-19) pandemic. National consensus 2020 // Cardiovask. sweat prof. - 2020. - T. 19, No. 4. - S. 135-172.9
9. Denisova A.R., Sivakova O.A., Blinova N.V. i dr. Osobennosti techeniya i podkhody k lecheniyu koronavirusnoy infektsii COVID-19 bolnykh s dechno-sudisticmi zabolevaniyami // Kardiol. vestn. - 2020. - T. 15, No. 3. - S. 64-71. 10
10. Mukhiddinov A.I., Tashkenbaeva E.N., Sunnatova G.I. i dr. Hypotensive therapy in patients with arterial hypertension and metabolic factors // Molodej i med. science v XXI v. - 2014. - R. 228-229.16
11. Mukhiddinov A.I., Sheranov A.M. Adylova N.A. i dr. Izuchenie sostoyaniya kachestvo jizni vrachey-terapevtov Samarkandskogo regiona // Akad. Journal. Western Siberia. - 2013. - T. 9, No. 3. - S. 20-21.17
12. Prevention, diagnosis and treatment of new coronavirus infection (COVID-19): temporary method. recommendation. – Version 7 (06/03/2020). 7
13. Tashkenbaeva E.N. i dr. Osobennosti klinicheskogo techeniya instabilnoy stenokardii s khronicheskoi sardechnoi dostatochnostyu u bolnykh s sokhrannoy fractsii vybrosa // Euraziyskiy kardiol. Journal. – 2019. – No. S1. - S. 279.13
14. Tashkenbaeva E.N., Mukhiddinov A.I., Togaeva B.M. (2019). Osobennosti klinicheskogo techenia bronchialnoy astmy u litz molodogo vozrasta // Evraziyskiy kardiol. Journal. - 2019. - T. 3. - S. 359.14
15. Tashkenbaeva E.N., Mukhiddinov A.I., Haydarova D.D. i dr. Specificity of the combined clinical course of hypertension and comorbid chronic obstructive pulmonary disease in patients at risk of developing cardiovascular complications with SOVID-19 // Vestn. TMA. – 2022. – No. 8. - S. 178.15
16. Tashkenbaeva E.N., Khasanjanova F.O., Kadyrova F.Sh. i dr. Osobennosti klinicheskogo techeniya instabilnoy stenokardii s khronicheskoi sardechnoi dostatochnostyu u bolnykh s sokhrannoy fractsii vybrosa // Euraziyskiy kardiol. Journal. – 2019. – S1. - S. 279.12
17. Khaidarova D.D., Mukhiddinov A.I., Tashkenbaeva E.N. i dr. Characteristics of arterial hypertension in patients at risk of developing cardiovascular complications in SOVID-19 // Vestn. TMA. – 2022. – No. 8. - S. 149.18
18. Baker Heart and Diabetes Institute, Melbourne, Australia. Public Health Directorate, Northern Territory Department of Health. Australia. DOI: 10.30824/2006-13
19. Cai G. Bulk and single-cell transcriptomics identify tobacco-use disparity in lung gene expression of ACE2, the receptor of 2019-ncov // Medrxiv. – 2020. Https://www.medrxiv.org/content/10.1101/ 2020.02.05.20020107v3
20. Goyal P et al. Clinical characteristics of COVID-19 in New York City // New Engl. J. Med. - 2020. - Vol. 382. – P. 2372-2374.